MRS. JENNIFER KOLSTAD PA-C
Prescription History 1659672921
Physician Assistant in Denver, CO

NPI Status: Active since November 03, 2010

Contact Information

2045 N FRANKLIN ST
DENVER, CO
ZIP 80205
Phone: (303) 338-4545

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MRS. JENNIFER KOLSTAD PA-C, an active Physician Assistant specialist practicing in Denver, CO. Our medical registry currently tracks 9 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 286 documented patient claims. Among these therapy options, the most frequently utilized medication is Lialda, which accounts for 65 claims alone.

Medication Index


Budesonide Dr

Generic Formulation: BudesonideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 380
CO State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills29.7
Peer Average Days Supply874
Conservative Utilization

This provider writes prescriptions for this formulation 34.8% less frequently than the standard regional baseline metric for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $835.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$55.73

State Avg Cost Per Claim

$130.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.

Therapeutic Applications

Budesonide is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

Lialda

Generic Formulation: MesalamineSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 65
30-Day Fills 118.0
Days Supply 3,540
CO State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills91.2
Peer Average Days Supply2,734
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 75.7% higher than the standard regional baseline profile for CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,040.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$416.01

State Avg Cost Per Claim

$544.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)

Therapeutic Applications

This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates. It works by decreasing swelling in the colon.

Linzess

Generic Formulation: LinaclotideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 27
30-Day Fills 37.0
Days Supply 1,110
CO State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills37.4
Peer Average Days Supply1,111
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,182.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$784.52

State Avg Cost Per Claim

$740.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. Linaclotide is used to treat certain types of bowel problems (irritable bowel syndrome with constipation, chronic idiopathic constipation). It works by increasing fluid in your intestines and helping speed up movement of food through the gut. Linaclotide may improve stool texture and lessen symptoms such as bloating, abdominal pain/discomfort, straining, and feelings of incomplete bowel movements.

Lubiprostone

Generic Formulation: LubiprostoneSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 39
30-Day Fills 90.0
Days Supply 2,700
CO State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills20.4
Peer Average Days Supply549
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 129.4% higher than the standard regional baseline profile for CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $15,477.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$396.86

State Avg Cost Per Claim

$318.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Member of a bicyclic fatty acid class of compounds derived from PROSTAGLANDIN E1 involved in chloride channel gating.

Therapeutic Applications

This medication is used to treat certain types of constipation (chronic idiopathic constipation, irritable bowel syndrome with constipation). Chronic idiopathic constipation has an unknown cause and is not due to diet, other diseases, or drugs. Lubiprostone is also used to treat constipation caused by opioid medications in people with ongoing pain due to medical conditions other than cancer. This medication may improve symptoms such as bloating and abdominal discomfort, improve stool texture, lessen the need to strain, and decrease the feeling of not completely relieving oneself. Lubiprostone belongs to a class of drugs known as chloride channel activators. It works by increasing the amount of fluid within your intestines, making the passage of stool easier.

Mesalamine

Generic Formulation: MesalamineSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 23
30-Day Fills 39.5
Days Supply 1,160
CO State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills36.8
Peer Average Days Supply1,085
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,903.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$300.15

State Avg Cost Per Claim

$801.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)

Therapeutic Applications

This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates. It works by decreasing swelling in the colon.

Omeprazole

Generic Formulation: OmeprazoleSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 53
30-Day Fills 83.0
Days Supply 2,475
CO State Average Benchmarks
Peer Average Claims71.0
Peer Average 30-Day Fills170.6
Peer Average Days Supply5,079
Conservative Utilization

This provider writes prescriptions for this formulation 25.4% less frequently than the standard regional baseline metric for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $535.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.11

State Avg Cost Per Claim

$17.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Therapeutic Applications

Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 29
30-Day Fills 76.0
Days Supply 2,280
CO State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills104.7
Peer Average Days Supply3,089
Conservative Utilization

This provider writes prescriptions for this formulation 39.6% less frequently than the standard regional baseline metric for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $364.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.56

State Avg Cost Per Claim

$20.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Trulance

Generic Formulation: PlecanatideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 24
30-Day Fills 34.0
Days Supply 1,020
CO State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills29.4
Peer Average Days Supply859
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,310.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$554.62

State Avg Cost Per Claim

$577.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. Plecanatide is used to treat certain types of bowel problems (chronic idiopathic constipation, irritable bowel syndrome with constipation). It works by increasing fluid in your intestines and helping speed up movement of food through the gut. Plecanatide may improve stool texture and lessen symptoms such as straining and feelings of incomplete bowel movements.

Xeljanz

Generic Formulation: Tofacitinib CitrateSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 330
CO State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills29.2
Peer Average Days Supply871
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 59.3% less volume than the regional standard for practitioners inside CO. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $52,154.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$4,741.35

State Avg Cost Per Claim

$4,344.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Tofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis-pcJIA). It helps to decrease pain/tenderness/swelling in the joints. Tofacitinib is also used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MRS. JENNIFER KOLSTAD PA-C provides transparency into local medical care patterns within Denver, CO.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physician Assistant** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.